CFLAR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.949000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.910400E-01
Normal-vs-Stage2
4.957400E-01
Normal-vs-Stage3
4.848800E-01
Normal-vs-Stage4
7.256000E-01
Stage1-vs-Stage2
3.513600E-01
Stage1-vs-Stage3
8.265400E-01
Stage1-vs-Stage4
4.170400E-01
Stage2-vs-Stage3
5.678400E-01
Stage2-vs-Stage4
9.462000E-01
Stage3-vs-Stage4
6.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.631600E-01
Normal-vs-AfricanAmerican
6.774200E-01
Normal-vs-Asian
5.455600E-01
Caucasian-vs-AfricanAmerican
8.146800E-01
Caucasian-vs-Asian
8.940400E-01
AfricanAmerican-vs-Asian
9.262000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.166000E-01
Normal-vs-Female
5.007200E-01
Male-vs-Female
5.476400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.772000E-01
Normal-vs-Age(41-60Yrs)
7.148200E-01
Normal-vs-Age(61-80Yrs)
3.052600E-01
Normal-vs-Age(81-100Yrs)
5.539400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.285400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.095600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.961400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.359800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.353800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.796000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.604400E-01
Normal-vs-Daily Drinker
4.982000E-01
Normal-vs-Weekly Drinker
9.382200E-01
Normal-vs-Occasional Drinker
4.457000E-01
Normal-vs-Social Drinker
5.167000E-01
Non Drinker-vs-Daily Drinker
2.793000E-01
Non Drinker-vs-Weekly Drinker
4.511800E-01
Non Drinker-vs-Occasional Drinker
9.755200E-01
Non Drinker-vs-Social Drinker
9.280600E-01
Daily Drinker-vs-Weekly Drinker
1.976000E-01
Daily Drinker-vs-Occasional Drinker
2.632600E-01
Daily Drinker-vs-Social Drinker
2.822000E-01
Weekly Drinker-vs-Occasional Drinker
4.670800E-01
Weekly Drinker-vs-Social Drinker
5.059800E-01
Occasional Drinker-vs-Social Drinker
9.508800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.979000E-01
Normal-vs-Grade 2
2.983800E-02
Normal-vs-Grade 3
1.450340E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.397120E-03
Grade 1-vs-Grade 3
7.612000E-04
Grade 1-vs-Grade 4
2.979000E-01
Grade 2-vs-Grade 3
4.884800E-01
Grade 2-vs-Grade 4
2.983800E-02
Grade 3-vs-Grade 4
1.450340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.559800E-01
Normal-vs-NonDiabetic
3.164800E-01
Diabetic-vs-NonDiabetic
7.276200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.361200E-01
Normal-vs-NoPancreatitis
3.272400E-01
Pancreatitis-vs-NoPancreatitis
3.455600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.059600E-01
Normal-vs-N1
4.435200E-01
N0-vs-N1
3.628800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.523400E-01
Normal-vs-TP53-NonMutant
2.997400E-01
TP53-Mutant-vs-TP53-NonMutant
1.453780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
